199
Views
2
CrossRef citations to date
0
Altmetric
Original Article

Predictors of health-related quality of life in patients with Crohn’s disease receiving biological therapy

ORCID Icon, ORCID Icon, , , &
Pages 1434-1441 | Received 18 Apr 2021, Accepted 23 Aug 2021, Published online: 07 Sep 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Joseph William Clinton & Raymond Keith Cross. (2023) Personalized Treatment for Crohn’s Disease: Current Approaches and Future Directions. Clinical and Experimental Gastroenterology 16, pages 249-276.
Read now

Articles from other publishers (1)

Jean-Frederic Colombel, Stefan Schreiber, Geert D’Haens, Joanne Rizzo, Kristina Kligys, Jenny Griffith, Javier Zambrano, Qian Zhou, Yafei Zhang, Jasmina Kalabic, Florian Rieder, Marla C Dubinsky & Remo Panaccione. (2023) Risankizumab Induction Therapy Achieves Early Symptom Improvements That Are Associated With Future Clinical and Endoscopic Outcomes in Crohn’s Disease: Post Hoc Analysis of the ADVANCE, MOTIVATE, and FORTIFY Phase 3 Studies. Journal of Crohn's and Colitis.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.